CARDIFF ONCOLOGY INC's ticker is CRDF and the CUSIP is 14147L108.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $500 | +49900.0% | 360 | -8.2% | 0.00% | – |
| Q1 2023 | $1 | – | 392 | +22.5% | 0.00% | – |
| Q4 2022 | $0 | -100.0% | 320 | -17.5% | 0.00% | – |
| Q2 2022 | $1,000 | -98.3% | 388 | -98.4% | 0.00% | -100.0% |
| Q1 2022 | $60,000 | +233.3% | 24,416 | +715.2% | 0.00% | – |
| Q4 2021 | $18,000 | -78.0% | 2,995 | -75.4% | 0.00% | -100.0% |
| Q3 2021 | $82,000 | -34.9% | 12,180 | -36.0% | 0.00% | -33.3% |
| Q2 2021 | $126,000 | +12500.0% | 19,017 | +25256.0% | 0.00% | – |
| Q4 2020 | $1,000 | -98.0% | 75 | -97.9% | 0.00% | -100.0% |
| Q3 2020 | $50,000 | – | 3,510 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 2,522,083 | $16,797,000 | 13.61% |
| Octagon Capital Advisors LP | 982,753 | $6,545,000 | 1.61% |
| Altium Capital Management LP | 348,888 | $2,324,000 | 0.61% |
| ACT CAPITAL MANAGEMENT, LLC | 102,500 | $683,000 | 0.35% |
| Eventide Asset Management | 1,670,399 | $11,125,000 | 0.15% |
| Artal Group S.A. | 750,000 | $4,995,000 | 0.11% |
| Virtus ETF Advisers LLC | 25,770 | $172,000 | 0.08% |
| HighVista Strategies LLC | 15,501 | $103,000 | 0.07% |
| ELKHORN PARTNERS LIMITED PARTNERSHIP | 13,500 | $90,000 | 0.05% |
| SCHOLTZ & COMPANY, LLC | 16,625 | $111,000 | 0.04% |